These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 1943483)
1. Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and sera. Akhtar S; Kole R; Juliano RL Life Sci; 1991; 49(24):1793-801. PubMed ID: 1943483 [TBL] [Abstract][Full Text] [Related]
4. Distribution of phosphodiester and phosphorothioate oligonucleotides in rat brain after intraventricular and intrahippocampal administration determined by in situ hybridization. Yaida Y; Nowak TS Regul Pept; 1995 Oct; 59(2):193-9. PubMed ID: 8584754 [TBL] [Abstract][Full Text] [Related]
5. Studies on anti-human immunodeficiency virus oligonucleotides that have alternating methylphosphonate/phosphodiester linkages. Miller PS; Cassidy RA; Hamma T; Kondo NS Pharmacol Ther; 2000 Mar; 85(3):159-63. PubMed ID: 10739870 [TBL] [Abstract][Full Text] [Related]
6. Syntheses of alternating oligo-2'-O-methylribonucleoside methylphosphonates and their interactions with HIV TAR RNA. Hamma T; Miller PS Biochemistry; 1999 Nov; 38(46):15333-42. PubMed ID: 10563819 [TBL] [Abstract][Full Text] [Related]
7. Cellular uptake mechanism for oligonucleotides: involvement of endocytosis in the uptake of phosphodiester oligonucleotides by a human colorectal adenocarcinoma cell line, HCT-15. Nakai D; Seita T; Terasaki T; Iwasa S; Shoji Y; Mizushima Y; Sugiyama Y J Pharmacol Exp Ther; 1996 Sep; 278(3):1362-72. PubMed ID: 8819524 [TBL] [Abstract][Full Text] [Related]
9. Treatment of the T98G glioblastoma cell line with antisense oligonucleotides directed toward mRNA encoding transforming growth factor-alpha and the epidermal growth factor receptor. Rubenstein M; Glick R; Lichtor T; Mirochnik Y; Chou P; Guinan P Med Oncol; 2001; 18(2):121-30. PubMed ID: 11778757 [TBL] [Abstract][Full Text] [Related]
10. Characterization of hybridization between synthetic oligodeoxynucleotides and RNA in living cells. Politz JC; Taneja KL; Singer RH Nucleic Acids Res; 1995 Dec; 23(24):4946-53. PubMed ID: 8559650 [TBL] [Abstract][Full Text] [Related]
11. Studies on the mechanism of stabilization of partially phosphorothioated oligonucleotides against nucleolytic degradation. Uhlmann E; Ryte A; Peyman A Antisense Nucleic Acid Drug Dev; 1997 Aug; 7(4):345-50. PubMed ID: 9303186 [TBL] [Abstract][Full Text] [Related]
12. Pseudo-cyclic oligonucleotides: in vitro and in vivo properties. Jiang Z; Kandimalla ER; Zhao Q; Shen LX; DeLuca A; Normano N; Ruskowski M; Agrawal S Bioorg Med Chem; 1999 Dec; 7(12):2727-35. PubMed ID: 10658577 [TBL] [Abstract][Full Text] [Related]
13. 3'-methylphosphonate-modified oligo-2'-O-methylribonucleotides and their Tat peptide conjugates: uptake and stability in mouse fibroblasts in culture. Prater CE; Miller PS Bioconjug Chem; 2004; 15(3):498-507. PubMed ID: 15149177 [TBL] [Abstract][Full Text] [Related]
14. Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology. Gao WY; Han FS; Storm C; Egan W; Cheng YC Mol Pharmacol; 1992 Feb; 41(2):223-9. PubMed ID: 1371582 [TBL] [Abstract][Full Text] [Related]